Meng Dong

11PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 27, 2026
Reduced Peritoneal NRF2 Immunoreactivity in Encapsulating Peritoneal Sclerosis and Its Implications for Redox Homeostasis.

|Sep 11, 2026
The FAP × CD3 bispecific antibody OMTX305 induces T cell-mediated antitumor effects in patient-derived ex vivo models of solid tumors.

|Mar 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.

Thomas L Ekstrom, Zhangshuai Dai, Julia Thiel

|Mar 18, 2026
Epigenetic context defines the transcriptional activity of canonical and noncanonical NF-κB signaling in pancreatic cancer.

Joana E Aggrey-Fynn, Joshua Busch, Dominik Saul

|Jan 31, 2026
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.

Stella Asmanidou, Julia Thiel, Thomas L Ekstrom

|Dec 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models.

Dina Mönch, Julia Thiel, Meng Dong

Pageof 2

Frequent Collaborators

6 joint publications

Julia Thiel

3 joint publications

Yael Aylon

3 joint publications

Steven A Johnsen

3 joint publications

Moshe Oren